Genentech will report new data on important progress for people with advanced cancers at asco 2012

Genentech, 05/17/2012

Genentech, a member of the Roche Group, announced that the company will present important new data from studies of several of its cancer medicines at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), June 1 to 5, 2012, in Chicago. At the meeting, data on Genentech's late–stage investigational and approved cancer medicines will be communicated in sessions that include 30 oral presentations.

Print Article Summary Cat 2 CME Report